Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0J2XD
|
|||
Former ID |
DNC005641
|
|||
Drug Name |
3-(5-Phenyl-oxazol-2-ylamino)-benzonitrile
|
|||
Synonyms |
3-[(5-phenyl-1,3-oxazol-2-yl)amino]benzonitrile; GW627834A; 2-Anilino-5-aryloxazole 10; AC1NS7R5; BDBM5849; CHEMBL192413; NCGC00241897-01; AB01092081-01; N-(3-Cyanophenyl)-5-phenyl-1,3-oxazol-2-amine Hydrochloride
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C16H11N3O
|
|||
Canonical SMILES |
C1=CC=C(C=C1)C2=CN=C(O2)NC3=CC=CC(=C3)C#N
|
|||
InChI |
1S/C16H11N3O/c17-10-12-5-4-8-14(9-12)19-16-18-11-15(20-16)13-6-2-1-3-7-13/h1-9,11H,(H,18,19)
|
|||
InChIKey |
VZMXZHOJAGFSNF-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
References | Top | |||
---|---|---|---|---|
REF 1 | Discovery and evaluation of 2-anilino-5-aryloxazoles as a novel class of VEGFR2 kinase inhibitors. J Med Chem. 2005 Mar 10;48(5):1610-9. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.